Data-driven identification of heart failure disease states and progression pathways using electronic health records.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 10 2022
Historique:
received: 18 10 2021
accepted: 13 10 2022
entrez: 26 10 2022
pubmed: 27 10 2022
medline: 28 10 2022
Statut: epublish

Résumé

Heart failure (HF) is a leading cause of morbidity, healthcare costs, and mortality. Guideline based segmentation of HF into distinct subtypes is coarse and unlikely to reflect the heterogeneity of etiologies and disease trajectories of patients. While analyses of electronic health records show promise in expanding our understanding of complex syndromes like HF in an evidence-driven way, limitations in data quality have presented challenges for large-scale EHR-based insight generation and decision-making. We present a hypothesis-free approach to generating real-world characteristics and progression patterns of HF. Patient disease state snapshots are extracted from the complaints mentioned in unstructured clinical notes. Typical disease states are generated by clustering and characterized in terms of their distinguishing features, temporal relationships, and risk of important clinical events. Our analysis generates a comprehensive "disease phenome" of real-world patients computed from large, noisy, secondary-use EHR datasets created in a routine clinical setting.

Identifiants

pubmed: 36284167
doi: 10.1038/s41598-022-22398-4
pii: 10.1038/s41598-022-22398-4
pmc: PMC9596465
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17871

Informations de copyright

© 2022. The Author(s).

Références

EGEMS (Wash DC). 2017 Sep 04;5(1):14
pubmed: 29881734
Nat Rev Cardiol. 2011 Jan;8(1):30-41
pubmed: 21060326
J Am Heart Assoc. 2017 Mar 30;6(4):
pubmed: 28360225
Sci Rep. 2018 Mar 9;8(1):4216
pubmed: 29523868
Adv Exp Med Biol. 2018;1067:219-238
pubmed: 29159789
Nat Commun. 2020 Jun 26;11(1):3223
pubmed: 32591506
Circ Cardiovasc Qual Outcomes. 2019 Oct;12(10):e005114
pubmed: 31610714
Eur J Heart Fail. 2017 Dec;19(12):1574-1585
pubmed: 28386917
Sci Rep. 2020 Dec 7;10(1):21340
pubmed: 33288774
Int J Epidemiol. 2010 Oct;39(5):1279-90
pubmed: 20591986
Circulation. 2007 Oct 9;116(15):1725-35
pubmed: 17923583
JACC Heart Fail. 2018 Mar;6(3):246-256
pubmed: 29428439
BMC Med Inform Decis Mak. 2020 Feb 3;20(1):16
pubmed: 32013925
Lancet. 2019 Mar 9;393(10175):1034-1044
pubmed: 30860029
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
J Am Med Inform Assoc. 2019 Nov 1;26(11):1189-1194
pubmed: 31414700
Eur J Heart Fail. 2019 Jun;21(6):770-778
pubmed: 30919549
Circulation. 2007 Apr 17;115(15):1975-81
pubmed: 17420346
Sci Rep. 2016 May 17;6:26094
pubmed: 27185194
Eur J Heart Fail. 2016 Apr;18(4):402-10
pubmed: 26754527
Eur J Heart Fail. 2017 Apr;19(4):469-478
pubmed: 27976514
J Biomed Inform. 2021 Mar;115:103686
pubmed: 33493631
Tidsskr Nor Laegeforen. 1999 Apr 20;119(10):1456-9
pubmed: 10354755
Arch Neurol. 2009 Nov;66(11):1400-6
pubmed: 19901173
Front Physiol. 2018 May 15;9:488
pubmed: 29867540
JMIR Med Inform. 2019 Apr 27;7(2):e12239
pubmed: 31066697
IEEE J Biomed Health Inform. 2018 Sep;22(5):1589-1604
pubmed: 29989977
J Am Med Inform Assoc. 2016 Apr;23(e1):e20-7
pubmed: 26338219
JAMA. 2018 Sep 4;320(9):867-868
pubmed: 30105359
Circ Heart Fail. 2020 Feb;13(2):e006472
pubmed: 32059630
Circ Heart Fail. 2016 Sep;9(9):
pubmed: 27582282
J Am Med Inform Assoc. 2013 Dec;20(e2):e232-8
pubmed: 24001516
Cochrane Database Syst Rev. 2020 Feb 27;2:CD012466
pubmed: 32103487
Eur Heart J. 2019 Jul 1;40(26):2155-2163
pubmed: 30957868
J Cardiol. 2011 Jan;57(1):8-17
pubmed: 21030212
J Card Fail. 2014 Jul;20(7):459-64
pubmed: 24709663
JACC Heart Fail. 2018 Aug;6(8):689-697
pubmed: 30007557
JAMA Netw Open. 2020 Jan 3;3(1):e1918962
pubmed: 31922560
AMIA Annu Symp Proc. 2015 Nov 05;2015:1937-46
pubmed: 26958293
Stroke. 2003 Dec;34(12):2930-4
pubmed: 14615618
JAMA Cardiol. 2018 Oct 1;3(10):1011-1019
pubmed: 30140928
Card Fail Rev. 2019 May 24;5(2):74-77
pubmed: 31179015

Auteurs

Tasha Nagamine (T)

Droice Research, New York, NY, USA.

Brian Gillette (B)

Department of Surgery, NYU Langone Long Island, Mineola, NY, USA.
Department of Foundations of Medicine, NYU Long Island School of Medicine, Mineola, NY, USA.

John Kahoun (J)

Droice Research, New York, NY, USA.
Clinical Informatics, CityMD, New York, NY, USA.

Rolf Burghaus (R)

Bayer AG, Wuppertal, Germany.

Jörg Lippert (J)

Bayer AG, Wuppertal, Germany.

Mayur Saxena (M)

Droice Research, New York, NY, USA. mayur@droicelabs.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH